This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Pediatric Neurology Briefs (Jun 2002)
Affiliations
Read online
The efficacy and safety of levetiracetam (LEV) as adjunctive therapy were evaluated in 23 children (aged 6-12 years) with monotherapy-resistant partial-onset seizures at Children’s Hospital Medical Center, Cincinnati, OH and other major centers.